Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2023

Apr 13, 2023

60507_rns_2023-04-13_12947522-3473-474a-a818-3c8e30612198.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

April 13, 2023

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Compliance Certificate – Regulation 40 (9) of the SEBI (LODR) Regulations, 2015

In compliance with Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate given by the Practicing Company Secretary, M/s. Manish Ghia & Associates, for the year ended March 31, 2023.

Please take the above on record.

Thanking you,

Yours truly,

For Pfizer Limited

Digitally signed by PRAJEET NAIR DN: c=IN, o=Personal, 2.5.4.20=9933a48702916ad69ca05ea07b057e4a4 PRAJEET 737e501e65094b9d54663b70517bbe5, postalCode=400054, st=MAHARASHTRA, serialNumber=c24aea3eb0ba76c8cf19782a6242b 9b35252d6b9461f59c3998022881b762db1, cn=PRAJEET NAIR, l=MUMBAI, title=7345, pseudonym=734520210415120738822, NAIR [email protected] Date: 2023.04.13 17:02:41 +05'30'

Prajeet Nair Director – Corporate Services & Company Secretary

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

==> picture [562 x 82] intentionally omitted <==

CERTIFICATE UNDER REGULATION 40 (9) OF SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE FINANCIAL YEAR ENDED 31[st ] MARCH, 2023

TO WHOMSOEVER IT MAY CONCERN

We have examined all Registers, files and other documents relating to Pfizer Limited having its registered office at The Capital, 1802/1901, Plot No. C-70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400051 maintained by KFin Technologies Limited (formerly known as KFin Technologies Private Limited) , the Registrar & Share Transfer Agent (RTA) of the Company pertaining to sub-division, consolidation, renewal, exchange or endorsement of calls/ allotment monies of equity shares of the Company during the year ended 31[st ] March, 2023 for the purpose of issuing Certificate as per Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 to Pfizer Limited and based on information provided by the Company, we hereby certify that during the year ended on 31[st ] March, 2023 the Company:

  • a) has issued letters of confirmation, wherever required, relating to request(s) for issue of duplicate share certificate(s) in lieu of original lost/misplaced and consolidation of share certificate received, within 30 days from the date of lodgement; and

  • b) has not received any request for sub-division, renewal, exchange or endorsement of calls/ allotment monies.

Place: Ghaziabad Date: April 13, 2023 UDIN: F007343E000086477

==> picture [84 x 84] intentionally omitted <==

==> picture [154 x 138] intentionally omitted <==

----- Start of picture text -----

For Manish Ghia & Associates
Company Secretaries
(Unique ID: P2006MH007100)
Digitally signed by
PANKAJ PANKAJ KUMAR NIGAM
KUMAR NIGAM Date: 2023.04.13
15:50:39 +05'30'
Pankaj Kumar Nigam
Partner
M. No. FCS 7343, C.P. No. 7979
PR 822/2020
----- End of picture text -----

==> picture [561 x 34] intentionally omitted <==

Page 1 of 1